Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience.Vigil Neuroscience, a biotechnology company harnessing the power of microglia…
Vigil Neuroscience’s $90 Million Series B Financing
